http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100065292-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e559abcd8f120b071dc1162360867ffa |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N45-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N35-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-02 |
| filingDate | 2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e55ab54daaabb63c284d79591ab2a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1af5f082e0c4b1074a2b0e34f14bcd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b27e07bc45ee03259928d2ac09fc725 |
| publicationDate | 2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100065292-A |
| titleOfInvention | Improvement of or related to organic compound |
| abstract | The present invention provides a composition comprising at least one biologically active compound comprising a compound of formula (I) and at least one aromatic five- and / or six-membered ring, wherein the ring contains at least one nitrogen as a reducing member, only, (i) the compound of formula I is N-butoxypropyl lactamide; 1- (hydroxyethyl) piperidinyl lactamide; N-methyl-N-propyl lactamide; N- (1-ethylpropyl) lactamide; N, N-dimethyl lactamide; N-1,4-dimethylpentyl lactamide; N- (2-hydroxyethyl) -N-benzyl lactamide; N-morpholinyl lactamide; N-methyl-N-butyl lactamide; N-isobutyl lactamide; N-allyl lactamide; N-ethyl lactamide; N-ethyl-N- (2-hydroxyethyl) lactamide; And N-isopropyl lactamide, the composition does not contain ciproconazole, (ii) When the compound of formula (I) is diethyl-lactamide, the biologically active compound is not nicotinic acid. Formula I In Formula I, R 1 and R 2 are each independently hydrogen; Or optionally by phenyl, hydroxy, C 1 -5 alkoxy, morpholinyl and NR 3 R 4 substituents to three independently from (wherein, R 3 and R 4 are each independently a C 1 -3 alkyl) selected substituted C 1 -6 alkyl, C 2 -6 alkenyl or C 3 -6 cycloalkyl; Or phenyl optionally substituted with up to 3 substituents independently selected from C 1-3 alkyl; R 1 and R 2 together with the nitrogen atom to which they are attached form a morpholinyl, pyrrolidinyl, piperidinyl or azepanyl ring optionally substituted with up to 3 substituents independently selected from C 1-3 alkyl. The compound of formula (I) is dimethyl lactamide, and the biologically active compound is a fungicide 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-isopropyl-1,2, Especially in the case of 3,4-tetrahydro-1,4-methano-naphthalen-5-yl) -amide such a composition can be an emulsion concentrate or can be included in an emulsion concentrate. |
| priorityDate | 2007-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.